![Àå³»½ÃÀå ´º½º](/images/2008/stock/bar_06.gif) |
Home ÄÚ½º´Ú/°Å·¡¼Ò Àå³»½ÃÀå ´º½º |
|
|
Á¦¸ñ : ¿Ã¸²Çª½ºÇѱ¹, ¼¼°è¼Òȱ⳻½Ã°æÇÐȸ ¡®ENDO 2024¡¯ Âü°¡
|
![Å©°Ôº¸±â](/images/0706/kosdaq-news-zoomin.gif) |
![ÀÛ°Ôº¸±â](/images/0706/kosdaq-news-zoomout.gif) |
![ÀμâÇϱâ](/images/0706/kosdaq-news-print.gif) |
![¸ñ·Ïº¸±â](/images/0706/kosdaq-news-list.gif) |
|
|
2024³â 07¿ù 03ÀÏ 09:22 ÇѼºÁÖ ±âÀÚ |
¿Ã¸²Çª½ºÇѱ¹, ¼¼°è¼Òȱ⳻½Ã°æÇÐȸ ¡®ENDO 2024¡¯ Âü°¡ |
![](http://test.38.co.kr/files/etoday/news/11670344_2045979.jpg)
¿Ã¸²Çª½ºÇѱ¹ÀÌ 4ÀϺÎÅÍ 6ÀϱîÁö ¼¿ï ÄÚ¿¢½º¿¡¼ ¿¸®´Â Á¦4ȸ ¼¼°è¼Òȱ⳻½Ã°æÇÐȸ(ENDO 2024)¿¡ Âü°¡ÇÑ´Ù°í 3ÀÏ ¹àÇû´Ù.
ENDO´Â ±¹Á¦ ÇÐȸ·Î À̹ø¿¡ Çѱ¹¿¡¼ °³ÃÖµÇ¸ç ¼¼°è³»½Ã°æ±â±¸(WEO)¿Í ´ëÇѼÒȱ⳻½Ã°æÇÐȸ(KSGE)°¡ ÇÔ²² ÁÖÃÖÇÑ´Ù. ¿ÃÇØ´Â ±¹Á¦¼Òȱ⳻½Ã°æ³×Æ®¿öÅ© Çмú´ëȸÀÎ ¡®IDEN 2024¡¯¿Í ÇÔ²² °³ÃֵȴÙ.
¿Ã¸²Çª½º ¾Æ½Ã¾Æ ÅÂÆò¾ç(APAC) Áö¿ª º»ºÎ¿Í ¿Ã¸²Çª½ºÇѱ¹Àº À̹ø ÇÐȸ¿¡ Âü¿©ÇØ ·±Ãµ ¹× Á¶Âù ½ÉÆ÷Áö¾öÀ» Áö¿øÇÑ´Ù. ¶ÇÇÑ, ÀÚ»ç Á¦Ç°À» Àü½Ã ¹× ¼Ò°³ÇÏ´Â ºÎ½º¸¦ ¸¶·ÃÇØ Çѱ¹»Ó¸¸ ¾Æ´Ï¶ó ¾Æ½Ã¾Æ Áö¿ªÀÇ Àú¸íÇÑ ÀÇ·áÁø°úµµ ¼ÒÅëÇÒ ¿¹Á¤ÀÌ´Ù.
5ÀÏ ·±Ãµ ½ÉÆ÷Áö¾ö¿¡´Â ENDO °øµ¿ ȸÀåÀ» ¸ÃÀº ÀüÈÆÀç °í·Á´ëÇб³¾È¾Ïº´¿ø ±³¼ö°¡ ÁÂÀåÀ¸·Î, Á¤Çö¼ö ¼¿ï´ëÇб³º´¿ø ±³¼ö°¡ ¡®»óºÎ À§Àå°ü ³»½Ã°æÀÇ »õ·Î¿î Æз¯´ÙÀÓ, À̺ñ½º ¿¢½º¿ø(New generation EVIS X1 for upper GI tract)¡¯À̶ó´Â ÁÖÁ¦·Î °¿¬À» ÁøÇàÇÑ´Ù.
¶Ç ÀϺ» »ç³ëº´¿øÀÇ »ç³ë ¾ß½º½Ã(Yasushi Sano) ±³¼ö´Â ¡®À̺ñ½º ¿¢½º¿ø¡¯°ú EDOF ½ºÄÚÇÁÀÇ ÀÓ»óÀû ÇýÅÃ(Clinical benefit of CV-1500 and EDOF - how it impacts your practice?)¡¯À̶õ ÁÖÁ¦·Î °¿¬À» ÁøÇàÇÑ´Ù.
°°Àº ³¯ Á¶Âù ½ÉÆ÷Áö¾ö¿¡¼´Â Åä¾ß¸¶´ëÇкμӺ´¿øÀÇ ¾ß½º´Ù ÀÌÄ¡·Î(Ichiro Yasuda) ±³¼ö°¡ ÁÂÀåÀ» ¸Ã°í, ¹Ú¼¼¿ì ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø ±³¼ö°¡ ¡®»õ·Î¿î ERCP ¹× EUS óġ±¸(Novel ERCP and EUS Devices)¡¯¸¦ ÁÖÁ¦·Î °¿¬À» ÁøÇàÇÑ´Ù.
¿Ã¸²Çª½ºÇѱ¹Àº À̹ø ÇÐȸ ºÎ½º¿¡¼ ¼Òȱâ ÁúȯÀÇ Áø´Ü°ú Ä¡·á¿¡ »ç¿ëµÇ´Â ÀÚ»çÀÇ ÃֽŠ³»½Ã°æ ½Ã½ºÅÛ°ú ´Ù¾çÇÑ Ã³Ä¡±¸ ¹× ³»½Ã°æ ¼Òµ¶ ¼¼Ã´±â µîÀ» Àü½ÃÇÑ´Ù. ½Ç½Ã°£ ½Ã¿¬(Live Demonstration) ¹× ÇÚÁî ¿Â(Hands-on) ÇÁ·Î±×·¥µµ ÁغñÇß´Ù.
¹ÚÀÎÁ¦ ¿Ã¸²Çª½ºÇѱ¹ »ç¾÷ÃÑ°ýºÎ¹®ÀåÀº "À̹ø ENDO 2024¸¦ ÅëÇØ ³»½Ã°æ °ü·Ã ÃֽŠÁö½Ä°ú ±â¼úÀ» °øÀ¯ÇØ ±â»Ú´Ù¡±¶ó¸ç ¡°¾ÕÀ¸·Îµµ ¿Ã¸²Çª½ºÇѱ¹Àº ±Û·Î¹ú ÀÇ·á±â¾÷À¸·Î¼ ȯÀÚÀÇ »îÀÇ Áú Çâ»ó¿¡ ±â¿©Çϱâ À§ÇØ ÀÚ»çÀÇ Çõ½Å Á¦Ç°ÀÇ ¿ì¼ö¼ºÀ» ÀÇ·á Àü¹®°¡µé°ú Àû±ØÀûÀ¸·Î ¼ÒÅëÇÏ´Â µ¥ ÃÖ¼±À» ´ÙÇÏ°Ú´Ù¡±°í ÀüÇß´Ù.
<ÀúÀÛ±ÇÀÚ ¨Ï ÀÌÅõµ¥ÀÌ ¹«´ÜÀüÀç/Àç¹èÆ÷ ±ÝÁö>
|
|
|
|
|
¿Ã¸²Çª½ºÇѱ¹, ¼¼°è¼Òȱ⳻½Ã°æÇÐȸ ¡®ENDO 2024¡¯ Âü°¡
Àå¿Ü½ÃÀå,ºñ»óÀå½ÃÀå,Àå¿ÜÁÖ½Ä,ºñ»óÀåÁÖ½Ä,¼Ò¾×ÁÖÁÖ,ÁÖÁÖµ¿È£È¸,ÁÖÁÖ°Ô½ÃÆÇ,°ø¸ð,¼Ò¾×°ø¸ð,Àå¿Ü½ÃȲ,ºñ»óÀåÁֽĽü¼,ÁÖ½ÄÂ÷Æ®,ÁÖ°¡,ºñ»óÀåÁֽİŷ¡,½Ã¼¼Á¤º¸,ÇÁ¸®º¸µå,Àå¿Ü½ÃÀå,ÇÁ¸®º¸µå½ÃÀå,Àå¿ÜÁÖ½Ä,ÇÁ¸®º¸µåÁÖ½Ä,¼Ò¾×ÁÖÁÖ,ÁÖÁÖµ¿È£È¸,ÁÖÁÖ°Ô½ÃÆÇ,°ø¸ð,¼Ò¾×°ø¸ð,½ÃȲ,½Ã¼¼,ÁÖ½ÄÂ÷Æ®,ÁÖ°¡,3½ÃÀå,ÅõÀÚÀü·«,Á¾¸ñºÐ¼®,¼±¹°¿É¼Ç,ÇØ¿ÜÁõ½Ã,ÁֽĽü¼ µî Áõ±ÇÁ¤º¸,Áõ±ÇÁ¤º¸»çÀÌÆ®,Áõ±Ç½Ã¼¼,¼±¹°¿É¼Ç,ÁÖ°¡Á¤º¸,Á¾¸ñÅä·Ð,Àü¹®°¡,Å׸¶ÁÖ ºÐ¼®,ÃßõÁ¾¸ñ,À̽´,Á¾¸ñ´º½º,Â÷Æ®,½ÃȲÀü·«,ÁÖ½ÄÅõÀÚ,Áõ±Ç Àü¹® Æ÷ÅлçÀÌÆ®,ÀçÅ×Å©,ºÎµ¿»ê,â¾÷,Ä«Æä,ÁÖ½ÄÄ®·³,Áõ½Ãºê¸®ÇÎ,Áõ½ÃºÐ¼®,ÁÖ½ÄÅõÀÚÁ¤º¸,Áõ±ÇÅõÀÚÁ¤º¸,±ÝÀ¶Á¤º¸,Â÷Æ®ºÐ¼®,Áõ½ÃÀÏÁ¤,¼Ò¾×ÁÖÁÖ,Ä¿¹Â´ÏƼ,¸Å¸Å,Áֽİŷ¡,¿Â¶óÀÎÁõ±Ç,Á¾¸ñÃßÀü
ÁÖ½Ä,Æݵå,Áõ½ÃÀü¸Á,ÅõÀÚÆ÷ÅÐ »çÀÌÆ®,À繫ºÐ¼®,Áֽİø¸ð,Áõ½ÃÀÏÁ¤,Áõ±Ç»ç,ÄÚ½ºÇÇ,ÄÚ½º´Ú,³ª½º´Ú,°Å·¡¼Ò,Äڳؽº,Á¦3ÁֽĽÃÀå,ÁÖ°¡Áö¼ö,¹Ì±¹Áõ½Ã,ÀϺ»Áõ½Ã,¾Æ½Ã¾ÆÁõ½Ã,KOSDAQ,KOSPI,KONEX,KOSCOM,»ï¼ºsds,Àå¿ÜÅõÀÚ
|
|
|